摘要:
The present invention provides novel 13,14-didehydro-interphenylene-19-oxo-PGF.sub.1 compounds, which are useful for a variety of pharmacological purposes, e.g., antiasthmatic indications.
摘要:
The present invention provides novel 2-decarboxy-2-aminomethyl-19-hydroxy-19-methyl-PG compounds and methods for their preparation and pharmacological uses for the induction of prostaglandin-like effects.
摘要:
The present invention provides novel 19-hydroxy-19-methyl-4-oxo-PGI.sub.1 compounds which are useful for pharmacological purposes, e.g., anti-asthmatic indications.
摘要:
The present invention provides novel 19-hydroxy-6-oxo-PGF.sub.1 sulfonylamides which are useful for pharmacological purposes, e.g., anti-asthmatic indications.
摘要:
The present invention provides novel 2-decarboxy-2-aminomethyl-19-hydroxy-6-oxo-PGF.sub.1 compounds which are useful for pharmacological purposes, e.g., anti-asthmatic indications.
摘要:
Acyl-substituted phenyl esters of prostacyclin-type compounds, for example the 4-acetylphenyl ester of prostacyclin (PGI.sub.2) illustrated by the formula ##STR1## and including esters of the isomeric 6-hydroxy-PGI.sub.1 and 6-keto-PGF.sub.1.alpha. compounds, said esters having pharmacological activity. Processes for preparing them and the appropriate intermediates are disclosed.
摘要:
The present invention relates to novel acyl-substituted esters of 6,7-didehydro- or 7,8-didehydro-PGI.sub.1 compounds, e.g., the 4-acetylphenyl ester of such PGI.sub.1 analogs. These esters are characterized by pharmacological activity, being for example useful for the pharmacological purposes for which the corresponding free acids are employed.
摘要:
Prostacyclin and prostacyclin-type derivatives having a 19-hydroxy feature are disclosed, including processes for preparing them and the appropriate intermediates. The compounds are useful for pharmacological purposes such as inhibition of blood platelate aggregation.
摘要:
Acyl-substituted phenyl esters of prostacyclin-type compounds, for example the 4-acetylphenyl ester of prostacyclin (PGI.sub.2) illustrated by the formula ##STR1## and including esters of the isomeric 6-hydroxy-PGF.sub.1 and 6-keto-PGF.sub.1.alpha. compounds, said esters having pharmacological acitivity. Processes for preparing them and the appropriate intermediates are disclosed.
摘要:
This invention relates to certain structural analogs of 5,6-dihydroprostacyclin (PGI.sub.1) wherein the C-5 carbon atom is substituted by hydroxy. These novel 5-hydroxyprostacyclin-type compounds are smooth muscle stimulators.